RareSum logo — Empowering Healthcare Professionals with AI-powered research...

RareSum

Empowering Healthcare Professionals with AI-powered research and decision-support solutions for Rare Diseases.

Founded 2024 Turkey Turkey 8 employees Total: $50.00K AI, Health Care +1

General Information

Company Name RareSum
Founded Year 2024
Location Turkey Turkey
Founders / Decision Makers
Team member
Employees 8
Industries AI, Health Care, SaaS
Business Model B2B, SaaS
Revenue Model Subscription, Usage Based, Service Fee
Offices as of Sep 2026
Istanbul, Turkey Barcelona, Spain
Social

BounceWatch is an independent company data service, not affiliated with RareSum. To contact RareSum, visit raresum.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does RareSum compare?

A PDF of RareSum and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting RareSum soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

In The News Oct 01, 2026

Featured on Webrazzi: KWORKS Connect kapsamında sunum yapan 18 girişim

About RareSum

RareSum, founded in 2024, is a budding startup in the AI, Health Care, and SaaS industries, headquartered in Turkey. The company is dedicated to revolutionizing healthcare for patients with rare diseases through its innovative AI-powered solutions.

The company's slogan, "Empowering Healthcare Professionals with AI-powered research and decision-support solutions for Rare Diseases," captures its mission of utilizing advanced AI and data technologies to boost research efficiency, save time and resources, and expedite diagnostics.

RareSum employs a rare disease-specific algorithm approach, offering cutting-edge, user-friendly tools tailored for healthcare professionals. It also engages in various partnership models, aiming to collaborate closely with different healthcare stakeholders.

The company recently secured a $50.00K investment from Techventure VC on 01 February 2025, illustrating investor confidence in its potential to impact the healthcare sector meaningfully.

Business keywords: AI-powered healthcare solutions, Rare diseases decision support, Healthcare data technologies, Diagnostic process acceleration, Research efficiency tools, Healthcare professional empowerment, User-friendly medical tools, Rare disease algorithms, Healthcare partnerships, Medical research enhancement, Time-saving healthcare solutions, Resource-efficient diagnostics

Services & Products

AI-Powered Clinical Decision Support
Medical Data Structuring and Analysis
Intelligent Screening and Software Services
Customized AI Solutions for Research
Risk Stratification and Diagnostic Pathways

Target Customers

Physicians Healthcare Institutions Research Centers Pharmaceutical Companies Laboratories Insurance Companies

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Support Program $50.00K 1
Techventure VC
01 Feb 2025
Support Program Undisclosed 1
EIT Health
01 Jan 2024

RareSum Alternatives & Competitors

View All Alternatives
RareSum vs

AI-driven system connecting cancer patients to clinical trials in real time. Industrializing the onc...

Series B
103 employees
AI, Big Data
RareSum vs
Wuru
Wuru United States

Data analytics for healthcare management

Seed
26 employees
Analytics, Health Care
RareSum vs
Delphyr
Delphyr The Netherlands

Delphyr is a medical data platform that unlocks patient-level data analytics for busy clinicians.

15 employees
AI, Health Care

FAQ About RareSum

Empowering Healthcare Professionals with AI-powered research and decision-support solutions for Rare Diseases.
RareSum was founded in 2024.
RareSum is headquartered in Turkey. As of Sep 2026, it also has offices in Istanbul, Turkey and Barcelona, Spain.
RareSum operates in AI, Health Care and SaaS. Its work centres on AI-powered healthcare solutions, Rare diseases decision support, Healthcare data technologies and Diagnostic process acceleration. Its customers include Physicians, Healthcare Institutions and Research Centers.
RareSum has a B2B and SaaS business model. Its revenue comes from Subscription, Usage Based and Service Fee.
RareSum has approximately 8 employees.
RareSum has completed 2 funding rounds, raising a total of $50.00K.
RareSum offers: AI-Powered Clinical Decision Support, Medical Data Structuring and Analysis, Intelligent Screening and Software Services, Customized AI Solutions for Research, Risk Stratification and Diagnostic Pathways.
Top alternatives and competitors to RareSum include Massive Bio, Wuru, Delphyr, BEYOND GENOMiX, Tribun Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RareSum and Massive Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for RareSum, https://bouncewatch.com/company/raresum, updated 7 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes